The results of real-time PCR showed that mRNA expression of Axin2 and Survivin was significantly decreased after gigantol treatment in breast cancer MDA-MB-231 and MDA-MB-468 cells (Fig. 5a-b). Here, BIRC5 is linked to breast cancer.